Basel Medical (BMGL) news
Recent news
Basel Medical Group: Action is at an early stage, co is unable to predict such contingency or estimate any likely outcome at this time
Basel Medical Group Ltd (NASDAQ: BMGL) has seen recent price action that reflects early-stage momentum, with its stock rising 3.87% to close at $0.62 on increased trading volume. The stock is currently trading within a defined range, bounded by support at $0.59 and resistance at $0.65. This…
AInvest Wire · Aug 10, 2026Basel Medical Group: named as defendant in securities class action lawsuit filed July 23, 2026 - SEC filing
Basel Medical Group Ltd. (NASDAQ: BMGL) has been named as a defendant in a securities class action lawsuit filed on July 23, 2026. The lawsuit, announced by the Rosen Law Firm, alleges that the company may have issued materially misleading business information to the investing public, potentially…
AInvest Wire · Aug 10, 2026BMGL regains compliance with Nasdaq minimum bid price requirement
Basel Medical Group Ltd (NASDAQ: BMGL) has regained compliance with Nasdaq’s minimum bid price requirement, resolving a prior delisting risk. The company previously received notification from Nasdaq on January 23, 2026, that its 30-day closing bid price had fallen below the $1 threshold required…
AInvest Wire · Jul 10, 2026QingSong Health enters three-year strategic cooperation MOU with Basel Medical
Basel Medical Group Ltd (Nasdaq: BMGL) has entered into a three-year strategic cooperation Memorandum of Understanding (MOU) with QingSong Health, further expanding its network of partnerships in the healthcare sector. The agreement aims to enhance collaboration in areas such as patient care,…
AInvest Wire · Jun 10, 2026Basel Medical Group - board approves 1-for-12 reverse share split effective June 22, 2026
Basel Medical Group Ltd (Nasdaq: BMGL) announced that its board of directors has approved a 1-for-12 reverse stock split, effective June 22, 2026. The move is intended to address the company’s minimum bid price requirement . The reverse split will reduce the number of outstanding shares from…
AInvest Wire · Jun 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.